Header Logo

Connection

PAVAN REDDY to T-Lymphocytes

Back to Details
This is a "connection" page, showing publications PAVAN REDDY has written about T-Lymphocytes.
PAVAN REDDY
Connection Strength
4.706
T-Lymphocytes
  1. Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology. Nat Immunol. 2021 11; 22(11):1440-1451.
    View in: PubMed
    Score: 0.388
  2. RNA-seq of human T cells after hematopoietic stem cell transplantation identifies Linc00402 as a regulator of T cell alloimmunity. Sci Transl Med. 2021 03 17; 13(585).
    View in: PubMed
    Score: 0.373
  3. ER-to-Golgi transport and SEC23-dependent COPII vesicles regulate T cell alloimmunity. J Clin Invest. 2021 01 19; 131(2).
    View in: PubMed
    Score: 0.369
  4. ATG5-Dependent Autophagy Uncouples T-cell Proliferative and Effector Functions and Separates Graft-versus-Host Disease from Graft-versus-Leukemia. Cancer Res. 2021 02 15; 81(4):1063-1075.
    View in: PubMed
    Score: 0.365
  5. Targeting Signal 3 Extracellularly and Intracellularly in Graft-Versus-Host Disease. Front Immunol. 2020; 11:722.
    View in: PubMed
    Score: 0.351
  6. Mitochondrial Deacetylase SIRT3 Plays an Important Role in Donor T Cell Responses after Experimental Allogeneic Hematopoietic Transplantation. J Immunol. 2018 12 01; 201(11):3443-3455.
    View in: PubMed
    Score: 0.316
  7. Non-Coding RNA Mediated Regulation of Allogeneic T Cell Responses After Hematopoietic Transplantation. Front Immunol. 2018; 9:1110.
    View in: PubMed
    Score: 0.308
  8. SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses. Am J Pathol. 2016 10; 186(10):2679-91.
    View in: PubMed
    Score: 0.271
  9. Mature T cell responses are controlled by microRNA-142. J Clin Invest. 2015 Jul 01; 125(7):2825-40.
    View in: PubMed
    Score: 0.250
  10. BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood. 2015 Apr 23; 125(17):2724-8.
    View in: PubMed
    Score: 0.246
  11. Allogeneic T cell responses are regulated by a specific miRNA-mRNA network. J Clin Invest. 2013 Nov; 123(11):4739-54.
    View in: PubMed
    Score: 0.224
  12. Influence of donor microbiota on the severity of experimental graft-versus-host-disease. Biol Blood Marrow Transplant. 2013 Jan; 19(1):164-8.
    View in: PubMed
    Score: 0.207
  13. Combined Th2 cytokine deficiency in donor T cells aggravates experimental acute graft-vs-host disease. Exp Hematol. 2008 Aug; 36(8):988-96.
    View in: PubMed
    Score: 0.152
  14. Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models. J Clin Invest. 2024 Mar 01; 134(5).
    View in: PubMed
    Score: 0.114
  15. Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease. Nat Microbiol. 2024 Mar; 9(3):614-630.
    View in: PubMed
    Score: 0.114
  16. miR-142 controls metabolic reprogramming that regulates dendritic cell activation. J Clin Invest. 2019 04 08; 129(5):2029-2042.
    View in: PubMed
    Score: 0.081
  17. Microbial metabolite sensor GPR43 controls severity of experimental GVHD. Nat Commun. 2018 09 10; 9(1):3674.
    View in: PubMed
    Score: 0.078
  18. Advances in understanding the pathogenesis of graft-versus-host disease. Br J Haematol. 2016 Apr; 173(2):190-205.
    View in: PubMed
    Score: 0.066
  19. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nat Immunol. 2016 05; 17(5):505-513.
    View in: PubMed
    Score: 0.066
  20. Acute Graft-versus-Host Disease: Novel Biological Insights. Biol Blood Marrow Transplant. 2016 Jan; 22(1):11-6.
    View in: PubMed
    Score: 0.064
  21. Neddylation plays an important role in the regulation of murine and human dendritic cell function. Blood. 2013 Sep 19; 122(12):2062-73.
    View in: PubMed
    Score: 0.055
  22. Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc Natl Acad Sci U S A. 2012 Jan 10; 109(2):564-9.
    View in: PubMed
    Score: 0.049
  23. Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Sci Transl Med. 2011 Jan 26; 3(67):67ra8.
    View in: PubMed
    Score: 0.046
  24. Immunization with host-type CD8{alpha}+ dendritic cells reduces experimental acute GVHD in an IL-10-dependent manner. Blood. 2010 Jan 21; 115(3):724-35.
    View in: PubMed
    Score: 0.042
  25. Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J Clin Invest. 2008 Jul; 118(7):2562-73.
    View in: PubMed
    Score: 0.039
  26. Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects. Blood. 2003 Apr 01; 101(7):2877-85.
    View in: PubMed
    Score: 0.026
  27. Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis. J Clin Invest. 2017 Jun 30; 127(7):2441-2451.
    View in: PubMed
    Score: 0.018
  28. Blockade of individual Notch ligands and receptors controls graft-versus-host disease. J Clin Invest. 2013 Apr; 123(4):1590-604.
    View in: PubMed
    Score: 0.013
  29. Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood. 2003 Jul 15; 102(2):763-71.
    View in: PubMed
    Score: 0.007
  30. Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease. Blood. 2002 Mar 01; 99(5):1825-32.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.